Humor And News… Whatever.
Pending CDC approval, the FDA has authorized the use of Pfizer's BioNTech vaccine for distribution among twelve to fifteen year-olds. The vaccine had previously been approved for use in children sixteen and older. The approval should come soon - possibly as soon as Wednesday - and after CDC go-ahead, immunization can begin as early as …
According to data from Moderna's Phase 02 clinical trials, their variant-targeting booster shot, appears to offer protection against variants of the virus initially found in Brazil and South Africa, such as the so-called B.1.354, and P.1. In-trial testing of a 50-microgram dose of it's vaccine is currently being administered to previously-vaccinated individuals. According to data, …
Amid calls to waive patent protections on COVID vaccines, the Biden administration has signaled its support to share the technology with other nations that are still struggling with the virus. Other Countries such as India are currently experiencing a surge with COVID-19, and are in need of vaccines more so than the United States. According …
Pfizer is expected get full authorization from the FDA to begin using the COVID vaccine on children between the ages 02 and 11. The FDA is likewise expected to begin distributing the Pfizer-BioNTech coronavirus vaccine in teens 12 15 as early as next week. The pediatric safety study to determine the efficacy of the vaccine …
The Weekly News 